Step one for asthma treatment: β2-agonists or inhaled corticosteroids?

Drugs

Volumn 61, Issue 9, 2001, Pages 1231-1238

  Redington, A E ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; PLACEBO;

AIRWAY OBSTRUCTION; ASTHMA; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; LONG TERM CARE; LUNG FUNCTION; REMISSION; REVIEW; STEROID THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034888434     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161090-00001     Document Type: Review

References (64)

1. The British Guidelines on Asthma Management: 1995 Review and position statement
2. Japanese guidelines for the diagnosis and management of bronchial asthma
3. Cellular events in the bronchi in mild asthma and after bronchial provocation
4. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
5. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
6. Eosinophilic inflammation in asthma
7. Mast cells in bronchoalveolar lumen of patients with bronchial asthma
8. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects
9. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial reactivity
10. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity
11. Use of induced sputum cell counts to investigate airway inflammation in asthma
12. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
13. Airway mucosal inflammation even in patients with newly diagnosed asthma
14. Airway inflammation in mild intermittent and in persistent asthma
15. The relationship between airways inflammation and asthma severity
16. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
17. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma
18. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
19. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: A quantitative light and electron microscopic study
20. Placebo-controlled immunopathologic study of four months on inhaled corticosteroids in asthma
21. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study
22. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma
23. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: The effects of antiasthmatic treatment with budesonide or terbutaline
24. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate
25. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma
26. An inhaled steroid improves markers of airway inflammation in patients with mild asthma
27. Airway wall remodelling in asthma
28. Airway fibrosis in asthma: Mechanisms, consequences, and potential for therapeutic intervention
29. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
30. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
31. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive lung disease
32. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)?
33. Effect of early vs late intervention with inhaled corticosteroids in asthma
34. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
35. A case-control study of deaths from asthma
36. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
37. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use
38. A prospective study of the natural history of asthma: Remission and relapse rates
39. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline
40. Effect of prednisolone and beclomethasone dipropionate on airway responsiveness in asthma: A comparative study
41. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma
42. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
43. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics
44. Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained
45. Effect of 1 year daily treatment with 400 μg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics
46. Adult patients may outgrow their asthma: A 25-year follow-up study
47. A 15-year follow-up study of ventilatory function in adults with asthma
48. A prospective study of asthma in a rural community
49. Rate of decline of lung function in subjects with asthma
50. Decline of lung function in adults with bronchial asthma
51. Lung function in young adults who had asthma in childhood
52. Asthma and irreversible airflow obstruction
53. The relationship between age and duration of asthma and the presence of persistent airflow obstruction in asthma
54. Asthma in the elderly: A comparison between patients with recently acquired and long-standing disease
55. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'
56. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma
57. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction
58. Mortality in adults with self-reported asthma
59. Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomised controlled study
60. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: A 4-year prospective study